Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
Analytical Method Validation of High-Performance Liquid Chromatography and Stability-Indicating Study of Medroxyprogesterone Acetate Intravaginal Sponges.

Analytical chemistry insights

Batrawi N, Wahdan S, Abualhasan M.
PMID: 28469407
Anal Chem Insights. 2017 Feb 20;12:1177390117690152. doi: 10.1177/1177390117690152. eCollection 2017.

Medroxyprogesterone acetate is widely used in veterinary medicine as intravaginal dosage for the synchronization of breeding cycle in ewes and goats. The main goal of this study was to develop reverse-phase high-performance liquid chromatography method for the quantification of...

Cite
Batrawi N, Wahdan S, Abualhasan M. Analytical Method Validation of High-Performance Liquid Chromatography and Stability-Indicating Study of Medroxyprogesterone Acetate Intravaginal Sponges. Anal Chem Insights. 2017;12:1177390117690152doi: 10.1177/1177390117690152.
Batrawi, N., Wahdan, S., & Abualhasan, M. (2017). Analytical Method Validation of High-Performance Liquid Chromatography and Stability-Indicating Study of Medroxyprogesterone Acetate Intravaginal Sponges. Analytical chemistry insights, 121177390117690152. https://doi.org/10.1177/1177390117690152
Batrawi, Nidal, et al. "Analytical Method Validation of High-Performance Liquid Chromatography and Stability-Indicating Study of Medroxyprogesterone Acetate Intravaginal Sponges." Analytical chemistry insights vol. 12 (2017): 1177390117690152. doi: https://doi.org/10.1177/1177390117690152
Batrawi N, Wahdan S, Abualhasan M. Analytical Method Validation of High-Performance Liquid Chromatography and Stability-Indicating Study of Medroxyprogesterone Acetate Intravaginal Sponges. Anal Chem Insights. 2017 Feb 20;12:1177390117690152. doi: 10.1177/1177390117690152. eCollection 2017. PMID: 28469407; PMCID: PMC5345923.
Copy Download .nbib Format: NLM
Salivary Amylase Level in Bronchoalveolar Fluid as a Marker of Chronic Pulmonary Aspiration in Children.

Pediatric allergy, immunology, and pulmonology

Abu-Hasan M, Elmallah M, Neal D, Brookes J.
PMID: 26697264
Pediatr Allergy Immunol Pulmonol. 2014 Sep 01;27(3):115-119. doi: 10.1089/ped.2014.0348.

No abstract available.

Cite
Abu-Hasan M, Elmallah M, Neal D, et al. Salivary Amylase Level in Bronchoalveolar Fluid as a Marker of Chronic Pulmonary Aspiration in Children. Pediatr Allergy Immunol Pulmonol. 2014;27(3):115-119doi: 10.1089/ped.2014.0348.
Abu-Hasan, M., Elmallah, M., Neal, D., & Brookes, J. (2014). Salivary Amylase Level in Bronchoalveolar Fluid as a Marker of Chronic Pulmonary Aspiration in Children. Pediatric allergy, immunology, and pulmonology, 27(3), 115-119. https://doi.org/10.1089/ped.2014.0348
Abu-Hasan, Mutasim, et al. "Salivary Amylase Level in Bronchoalveolar Fluid as a Marker of Chronic Pulmonary Aspiration in Children." Pediatric allergy, immunology, and pulmonology vol. 27,3 (2014): 115-119. doi: https://doi.org/10.1089/ped.2014.0348
Abu-Hasan M, Elmallah M, Neal D, Brookes J. Salivary Amylase Level in Bronchoalveolar Fluid as a Marker of Chronic Pulmonary Aspiration in Children. Pediatr Allergy Immunol Pulmonol. 2014 Sep 01;27(3):115-119. doi: 10.1089/ped.2014.0348. PMID: 26697264; PMCID: PMC4678331.
Copy Download .nbib Format: NLM
Exercise in Children during Health and Sickness.

International journal of pediatrics

Abu-Hasan M, Armstrong N, Andersen LB, Weinberger M, Nixon PA.
PMID: 21253545
Int J Pediatr. 2010;2010:842537. doi: 10.1155/2010/842537. Epub 2010 Dec 29.

No abstract available.

Cite
Abu-Hasan M, Armstrong N, Andersen LB, et al. Exercise in Children during Health and Sickness. Int J Pediatr. 2010;2010:842537doi: 10.1155/2010/842537.
Abu-Hasan, M., Armstrong, N., Andersen, L. B., Weinberger, M., & Nixon, P. A. (2010). Exercise in Children during Health and Sickness. International journal of pediatrics, 2010842537. https://doi.org/10.1155/2010/842537
Abu-Hasan, Mutasim, et al. "Exercise in Children during Health and Sickness." International journal of pediatrics vol. 2010 (2010): 842537. doi: https://doi.org/10.1155/2010/842537
Abu-Hasan M, Armstrong N, Andersen LB, Weinberger M, Nixon PA. Exercise in Children during Health and Sickness. Int J Pediatr. 2010;2010:842537. doi: 10.1155/2010/842537. Epub 2010 Dec 29. PMID: 21253545; PMCID: PMC3021859.
Copy Download .nbib Format: NLM
Analytical Method Development for Sodium Valproate through Chemical Derivatization.

International journal of analytical chemistry

Abualhasan M, Odeh NW, Younis GN, Zeidan OF.
PMID: 32099545
Int J Anal Chem. 2020 Jan 31;2020:5672183. doi: 10.1155/2020/5672183. eCollection 2020.

BACKGROUND: Sodium valproate has anticonvulsant activity and is structurally different to conventional antiepileptic drugs. The problem with valproic acid is the lack of a chromophore, which means that gas chromatography is the sole assay methodology. The introduction of benzoyl...

Cite
Abualhasan M, Odeh NW, Younis GN, et al. Analytical Method Development for Sodium Valproate through Chemical Derivatization. Int J Anal Chem. 2020;2020:5672183doi: 10.1155/2020/5672183.
Abualhasan, M., Odeh, N. W., Younis, G. N., & Zeidan, O. F. (2020). Analytical Method Development for Sodium Valproate through Chemical Derivatization. International journal of analytical chemistry, 20205672183. https://doi.org/10.1155/2020/5672183
Abualhasan, Murad, et al. "Analytical Method Development for Sodium Valproate through Chemical Derivatization." International journal of analytical chemistry vol. 2020 (2020): 5672183. doi: https://doi.org/10.1155/2020/5672183
Abualhasan M, Odeh NW, Younis GN, Zeidan OF. Analytical Method Development for Sodium Valproate through Chemical Derivatization. Int J Anal Chem. 2020 Jan 31;2020:5672183. doi: 10.1155/2020/5672183. eCollection 2020. PMID: 32099545; PMCID: PMC7013335.
Copy Download .nbib Format: NLM
Using Mobile Health to Improve Asthma Self-Management in Early Adolescence: A Pilot Randomized Controlled Trial.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine

Fedele DA, Thomas JG, McConville A, McQuaid EL, Voorhees S, Janicke DM, Abu-Hasan M, Chi X, Gurka MJ.
PMID: 34274211
J Adolesc Health. 2021 Dec;69(6):1032-1040. doi: 10.1016/j.jadohealth.2021.06.011. Epub 2021 Jul 15.

PURPOSE: Early adolescence is an important developmental period where youth take primary responsibility for asthma self-management. Helpful caregiver support during this time is pivotal in determining whether early adolescents successfully develop asthma self-management behaviors. AIM2ACT is a dyadic mobile...

Cite
Fedele DA, Thomas JG, McConville A, et al. Using Mobile Health to Improve Asthma Self-Management in Early Adolescence: A Pilot Randomized Controlled Trial. J Adolesc Health. 2021;69(6):1032-1040doi: 10.1016/j.jadohealth.2021.06.011.
Fedele, D. A., Thomas, J. G., McConville, A., McQuaid, E. L., Voorhees, S., Janicke, D. M., Abu-Hasan, M., Chi, X., & Gurka, M. J. (2021). Using Mobile Health to Improve Asthma Self-Management in Early Adolescence: A Pilot Randomized Controlled Trial. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 69(6), 1032-1040. https://doi.org/10.1016/j.jadohealth.2021.06.011
Fedele, David A, et al. "Using Mobile Health to Improve Asthma Self-Management in Early Adolescence: A Pilot Randomized Controlled Trial." The Journal of adolescent health : official publication of the Society for Adolescent Medicine vol. 69,6 (2021): 1032-1040. doi: https://doi.org/10.1016/j.jadohealth.2021.06.011
Fedele DA, Thomas JG, McConville A, McQuaid EL, Voorhees S, Janicke DM, Abu-Hasan M, Chi X, Gurka MJ. Using Mobile Health to Improve Asthma Self-Management in Early Adolescence: A Pilot Randomized Controlled Trial. J Adolesc Health. 2021 Dec;69(6):1032-1040. doi: 10.1016/j.jadohealth.2021.06.011. Epub 2021 Jul 15. PMID: 34274211.
Copy Download .nbib Format: NLM
Pleuropulmonary Blastoma (PPB) in Child with .

Case reports in pulmonology

Hamad SG, Al-Naimi A, Abu-Hasan M.
PMID: 34745680
Case Rep Pulmonol. 2021 Oct 29;2021:1983864. doi: 10.1155/2021/1983864. eCollection 2021.

Pleuropulmonary blastoma (PPB) is a rare intrathoracic malignancy, which arises from the lung parenchyma and/or pleura. PPB has strong genetic association with mutations in

Cite
Hamad SG, Al-Naimi A, Abu-Hasan M. Pleuropulmonary Blastoma (PPB) in Child with . Case Rep Pulmonol. 2021;2021:1983864doi: 10.1155/2021/1983864.
Hamad, S. G., Al-Naimi, A., & Abu-Hasan, M. (2021). Pleuropulmonary Blastoma (PPB) in Child with . Case reports in pulmonology, 20211983864. https://doi.org/10.1155/2021/1983864
Hamad, Sara G, et al. "Pleuropulmonary Blastoma (PPB) in Child with ." Case reports in pulmonology vol. 2021 (2021): 1983864. doi: https://doi.org/10.1155/2021/1983864
Hamad SG, Al-Naimi A, Abu-Hasan M. Pleuropulmonary Blastoma (PPB) in Child with . Case Rep Pulmonol. 2021 Oct 29;2021:1983864. doi: 10.1155/2021/1983864. eCollection 2021. PMID: 34745680; PMCID: PMC8570905.
Copy Download .nbib Format: NLM
RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine.

International journal of analytical chemistry

Assali M, Abualhasan M, Zohud N, Ghazal N.
PMID: 32695171
Int J Anal Chem. 2020 Jul 01;2020:1894907. doi: 10.1155/2020/1894907. eCollection 2020.

BACKGROUND: Indomethacin is considered a potent nonsteroidal anti-inflammatory drug that could be combined with Paracetamol to have superior and synergist activity to manage pain and inflammation. To reduce the gastric side effect, they could be combined with Famotidine. RESULTS:...

Cite
Assali M, Abualhasan M, Zohud N, et al. RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine. Int J Anal Chem. 2020;2020:1894907doi: 10.1155/2020/1894907.
Assali, M., Abualhasan, M., Zohud, N., & Ghazal, N. (2020). RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine. International journal of analytical chemistry, 20201894907. https://doi.org/10.1155/2020/1894907
Assali, Mohyeddin, et al. "RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine." International journal of analytical chemistry vol. 2020 (2020): 1894907. doi: https://doi.org/10.1155/2020/1894907
Assali M, Abualhasan M, Zohud N, Ghazal N. RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine. Int J Anal Chem. 2020 Jul 01;2020:1894907. doi: 10.1155/2020/1894907. eCollection 2020. PMID: 32695171; PMCID: PMC7350129.
Copy Download .nbib Format: NLM
Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells.

Stem cell reviews and reports

Abdulhasan M, Ruden X, Rappolee B, Dutta S, Gurdziel K, Ruden DM, Awonuga AO, Korzeniewski SJ, Puscheck EE, Rappolee DA.
PMID: 34155611
Stem Cell Rev Rep. 2021 Dec;17(6):2164-2177. doi: 10.1007/s12015-021-10188-w. Epub 2021 Jun 21.

Stress-induced changes in viral receptor and susceptibility gene expression were measured in embryonic stem cells (ESC) and differentiated progeny. Rex1 promoter-Red Fluorescence Protein reporter ESC were tested by RNAseq after 72hr exposures to control stress hyperosmotic sorbitol under stemness...

Cite
Abdulhasan M, Ruden X, Rappolee B, et al. Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells. Stem Cell Rev Rep. 2021;17(6):2164-2177doi: 10.1007/s12015-021-10188-w.
Abdulhasan, M., Ruden, X., Rappolee, B., Dutta, S., Gurdziel, K., Ruden, D. M., Awonuga, A. O., Korzeniewski, S. J., Puscheck, E. E., & Rappolee, D. A. (2021). Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells. Stem cell reviews and reports, 17(6), 2164-2177. https://doi.org/10.1007/s12015-021-10188-w
Abdulhasan, Mohammed, et al. "Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells." Stem cell reviews and reports vol. 17,6 (2021): 2164-2177. doi: https://doi.org/10.1007/s12015-021-10188-w
Abdulhasan M, Ruden X, Rappolee B, Dutta S, Gurdziel K, Ruden DM, Awonuga AO, Korzeniewski SJ, Puscheck EE, Rappolee DA. Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells. Stem Cell Rev Rep. 2021 Dec;17(6):2164-2177. doi: 10.1007/s12015-021-10188-w. Epub 2021 Jun 21. PMID: 34155611; PMCID: PMC8216586.
Copy Download .nbib Format: NLM
Spectral characterization, antioxidant, antimicrobial, cytotoxic, and cyclooxygenase inhibitory activities of Aloysia citriodora essential oils collected from two Palestinian regions.

BMC complementary medicine and therapies

Jaradat N, Hawash M, Abualhasan MN, Qadi M, Ghanim M, Massarwy E, Ammar SA, Zmero N, Arar M, Hussein F, Issa L, Mousa A, Zarour A.
PMID: 34001110
BMC Complement Med Ther. 2021 May 17;21(1):143. doi: 10.1186/s12906-021-03314-1.

BACKGROUND: Aloysia citriodora Palau (AC) is commonly known as Lemon Verbena and has been utilized as a medicinal tea in folkloric medicine for the treatment of abdominal spasm, anxiety, and fever. The present investigation aimed to identify the chemical...

Cite
Jaradat N, Hawash M, Abualhasan MN, et al. Spectral characterization, antioxidant, antimicrobial, cytotoxic, and cyclooxygenase inhibitory activities of Aloysia citriodora essential oils collected from two Palestinian regions. BMC Complement Med Ther. 2021;21(1):143doi: 10.1186/s12906-021-03314-1.
Jaradat, N., Hawash, M., Abualhasan, M. N., Qadi, M., Ghanim, M., Massarwy, E., Ammar, S. A., Zmero, N., Arar, M., Hussein, F., Issa, L., Mousa, A., & Zarour, A. (2021). Spectral characterization, antioxidant, antimicrobial, cytotoxic, and cyclooxygenase inhibitory activities of Aloysia citriodora essential oils collected from two Palestinian regions. BMC complementary medicine and therapies, 21(1), 143. https://doi.org/10.1186/s12906-021-03314-1
Jaradat, Nidal, et al. "Spectral characterization, antioxidant, antimicrobial, cytotoxic, and cyclooxygenase inhibitory activities of Aloysia citriodora essential oils collected from two Palestinian regions." BMC complementary medicine and therapies vol. 21,1 (2021): 143. doi: https://doi.org/10.1186/s12906-021-03314-1
Jaradat N, Hawash M, Abualhasan MN, Qadi M, Ghanim M, Massarwy E, Ammar SA, Zmero N, Arar M, Hussein F, Issa L, Mousa A, Zarour A. Spectral characterization, antioxidant, antimicrobial, cytotoxic, and cyclooxygenase inhibitory activities of Aloysia citriodora essential oils collected from two Palestinian regions. BMC Complement Med Ther. 2021 May 17;21(1):143. doi: 10.1186/s12906-021-03314-1. PMID: 34001110; PMCID: PMC8130314.
Copy Download .nbib Format: NLM
Intracranial Stenting: Is It Still an Option for Treatment of Patients With Intracranial Atherosclerosis?.

Frontiers in neurology

Abualhasan A, Abd-Allah F, Pero G, Sobh K, Mansour O, El-Serafy O, Boccardi E.
PMID: 31824414
Front Neurol. 2019 Nov 22;10:1248. doi: 10.3389/fneur.2019.01248. eCollection 2019.

Intracranial atherosclerotic disease (ICAD) is considered a major cause of recurrent cerebrovascular events. ICAD continues to be a disease without an effective method of reducing the risk of recurrent stroke and death, even with aggressive, highly monitored medical treatment....

Cite
Abualhasan A, Abd-Allah F, Pero G, et al. Intracranial Stenting: Is It Still an Option for Treatment of Patients With Intracranial Atherosclerosis?. Front Neurol. 2019;10:1248doi: 10.3389/fneur.2019.01248.
Abualhasan, A., Abd-Allah, F., Pero, G., Sobh, K., Mansour, O., El-Serafy, O., & Boccardi, E. (2019). Intracranial Stenting: Is It Still an Option for Treatment of Patients With Intracranial Atherosclerosis?. Frontiers in neurology, 101248. https://doi.org/10.3389/fneur.2019.01248
Abualhasan, Ahmed, et al. "Intracranial Stenting: Is It Still an Option for Treatment of Patients With Intracranial Atherosclerosis?." Frontiers in neurology vol. 10 (2019): 1248. doi: https://doi.org/10.3389/fneur.2019.01248
Abualhasan A, Abd-Allah F, Pero G, Sobh K, Mansour O, El-Serafy O, Boccardi E. Intracranial Stenting: Is It Still an Option for Treatment of Patients With Intracranial Atherosclerosis?. Front Neurol. 2019 Nov 22;10:1248. doi: 10.3389/fneur.2019.01248. eCollection 2019. PMID: 31824414; PMCID: PMC6884030.
Copy Download .nbib Format: NLM
Gender differences and risk factors for smoking among patients with various psychiatric disorders in Saudi Arabia: a cross-sectional study.

International journal of mental health systems

Alosaimi FD, Abalhassan M, Alhaddad B, Fallata EO, Alhabbad A, Alshenqiti R, Alassiry MZ.
PMID: 29755581
Int J Ment Health Syst. 2018 May 03;12:21. doi: 10.1186/s13033-018-0201-7. eCollection 2018.

BACKGROUND: The higher prevalence of smoking among psychiatric patients is well established. However, gender-specific associations have rarely been the focus of studies among patients with various psychiatric disorders. The aim of this study was to estimate the gender-specific prevalence...

Cite
Alosaimi FD, Abalhassan M, Alhaddad B, et al. Gender differences and risk factors for smoking among patients with various psychiatric disorders in Saudi Arabia: a cross-sectional study. Int J Ment Health Syst. 2018;12:21doi: 10.1186/s13033-018-0201-7.
Alosaimi, F. D., Abalhassan, M., Alhaddad, B., Fallata, E. O., Alhabbad, A., Alshenqiti, R., & Alassiry, M. Z. (2018). Gender differences and risk factors for smoking among patients with various psychiatric disorders in Saudi Arabia: a cross-sectional study. International journal of mental health systems, 1221. https://doi.org/10.1186/s13033-018-0201-7
Alosaimi, Fahad D, et al. "Gender differences and risk factors for smoking among patients with various psychiatric disorders in Saudi Arabia: a cross-sectional study." International journal of mental health systems vol. 12 (2018): 21. doi: https://doi.org/10.1186/s13033-018-0201-7
Alosaimi FD, Abalhassan M, Alhaddad B, Fallata EO, Alhabbad A, Alshenqiti R, Alassiry MZ. Gender differences and risk factors for smoking among patients with various psychiatric disorders in Saudi Arabia: a cross-sectional study. Int J Ment Health Syst. 2018 May 03;12:21. doi: 10.1186/s13033-018-0201-7. eCollection 2018. PMID: 29755581; PMCID: PMC5934876.
Copy Download .nbib Format: NLM
Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia.

Journal of global infectious diseases

El-Nahas H, El-Shazly A, Abulhassan M, Nabih N, Mousa N.
PMID: 21887053
J Glob Infect Dis. 2011 Jul;3(3):227-32. doi: 10.4103/0974-777X.83527.

BACKGROUND: A major factor in the progression of lymphedema is acute dermatolymphangioadenitis (ADLA).AIMS: To study ADLA episodes and antigenaemia in patients with different grades of filarial lymphedema at pre- and two years post-treatment.SETTING AND DESIGN: A prospectively conducted study...

Cite
El-Nahas H, El-Shazly A, Abulhassan M, et al. Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia. J Glob Infect Dis. 2011;3(3):227-32doi: 10.4103/0974-777X.83527.
El-Nahas, H., El-Shazly, A., Abulhassan, M., Nabih, N., & Mousa, N. (2011). Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia. Journal of global infectious diseases, 3(3), 227-32. https://doi.org/10.4103/0974-777X.83527
El-Nahas, Ha, et al. "Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia." Journal of global infectious diseases vol. 3,3 (2011): 227-32. doi: https://doi.org/10.4103/0974-777X.83527
El-Nahas H, El-Shazly A, Abulhassan M, Nabih N, Mousa N. Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia. J Glob Infect Dis. 2011 Jul;3(3):227-32. doi: 10.4103/0974-777X.83527. PMID: 21887053; PMCID: PMC3162808.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries